The firm
NFXVC firm · US35cheques in 12 months191all time7ledCompanies they are listed as backing
Portfolio
La Jolla Labs
Mana Bio- Pangea Biomed
Where they are named on record
Filings
- SEC Form D · Company raisingTwoStep Therapeutics, Inc.Directorsince 2024
- SEC Form D · Company raisingresistanceBio, Inc.Directorsince 2024
- SEC Form D · Venture Capital fundNFXManaging Member of the GP of the GPon 3 filings · since 2023
- SEC Form D · Company raisingPepper Bio, Inc.Directoron 3 filings · since 2023
- SEC Form D · Company raisingGenome Compiler CorpExecutive Officer, Directorsince 2011
Each row is a document a firm filed with a regulator: somebody signed it, and it carries a date.
Hear them before you pitch them
Mentioned in
Episodes that name Omri Amirav-Drory in their description, which is not the same as being on them.
NFXBio: The Promise of Synthetic Embryos with Dr. Jacob Hanna of Renewal Bio
MentionsThe New York TimesOmri Amirav-Drory
About this episode
We're highlighting a breakthrough moment - this summer, Dr. Jacob Hanna, a professor at the Weizmann Institute of Science published a paper demonstrating that synthetic mouse embryos could be grown outside the womb, without an egg or sperm. This is a major advance that was covered by Nature, The… More on the show's page
Listen on
Apple PodcastsThe show's pageNFXBio: TechBio Platforms Developing a Universal Vaccine & Beating Treatment-Resistant Cancer
MentionsOmri Amirav-Drory
About this episode
In biology we have a saying: what doesn’t kill you mutates and tries again. Cancer. Deadly viruses. These problems are so hard to tackle because the goalposts are always moving. Thanks to evolution, these diseases often outpace therapies and vaccines. Today, NFX General Partner and Head of NFX Bio… More on the show's page
Listen on
Apple PodcastsThe show's pageNFXBio: Academia or Startup? A Decision Matrix for Future Scientist-Founders
MentionsOmri Amirav-DroryYaniv Erlich
About this episode
NFX Bio is committed to backing Scientist-Founders who are inspired to change the world. But there are far fewer scientists-Founders today than there should be. Instead, scientists often follow the path that academia paves for them: from graduate school, to a PhD, to a postdoc, to another role in… More on the show's page
Listen on
Apple PodcastsThe show's pageNFXBio: Why C2i is the World’s First Platform for Cancer Intelligence
MentionsAsaf ZviranOmri Amirav-Drory
About this episode
The team at C2i Genomics is combining cutting-edge genomics and sophisticated AI to provide the world’s first whole-genome cancer intelligence platform, transforming the way cancer is monitored and treated. C2i uses a blood test that can detect and quantify tiny amounts of residual cancer to better… More on the show's page
Listen on
Apple PodcastsThe show's page
Episodes of the shows we follow, matched by name. Not them? Tell us.
Find people like Omri
Filter every partner and angel by firm, kind, market and whether we watched them invest. Free with an account.